Skip to main content

Table 3 Additional information

From: Comprehensive genomic evaluation of advanced and recurrent breast cancer patients for tailored precision treatments

 

Number of patients

BRCA1/2 mutation

 

   Yes

1*

   No

21

MSI

 

   High

0

   Stable

20

   CD

2

TMB

 

   ≥ 10

3

    0–9

17

   CD

2

TMB score (muts/Mb)

 

   Median (range)

3.0 (0–11)

  1. CD: Data cannot be determined due to the low quality of the sample
  2. * BRCA2 reversion mutation was recognized in this patient
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us